🔴 Clearpoint Neuro is trading 5% down amid possible healthcare-sector pressure

Clearpoint Neuro is trading at $11.59, down 5.08% on October 1, 2026; no new company-specific announcement explaining the decline surfaced in the search.

• Supplied sector context shows XLV down 1.33% during the session; healthcare-sector weakness may be contributing.
• A September 29 uniQure trial setback was reported as prompting a sharp Clearpoint Neuro selloff, but it does not establish the cause of the October 1 move.